The Research Race to Make Drugs More Efficient. Darrell Sleep. WSJ May 2014
Pub type: VELTIS
"Drug companies are researching ways to boost the power of existing drugs—a path to better medicine at a time when inventing new drugs is increasingly difficult. Albumin is an optimal material upon which to base half-life extension technologies due to its naturally long half-life of 19 days in humans, in comparison to protein therapeutics that are often cleared from the body in as little as hours."